2-甲砜基-5-溴-4-嘧啶甲酸 | 30321-94-9

• 物质功能分类: 医药中间体 - 杂环化合物 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 2-甲砜基-5-溴-4-嘧啶甲酸
• 中文别名: 2-甲基磺酰基-5-溴嘧啶-4-羧酸
• 英文名称: 2-Methansulfonyl-5-brom-4-pyrimidincarbonsaeure
• 英文别名: 5-bromo-2-methanesulfonyl-pyrimidine-4-carboxylic acid；2-Methylsulfonyl-5-bromopyrimidine-4-carboxylic acid；5-bromo-2-methylsulfonylpyrimidine-4-carboxylic acid
• CAS: 30321-94-9
• 化学式: C₆H₅BrN₂O₄S
• mdl: MFCD06742786
• 分子量: 281.087
• InChiKey: UEYGRSDYBWXDKJ-UHFFFAOYSA-N

物化性质

• 沸点：
  525.4±60.0 °C(Predicted)
• 密度：
  1.920±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.166
• 拓扑面积：
  106
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933599090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335

反应信息

• 作为反应物：
  描述：

  吗啉 、 2-甲砜基-5-溴-4-嘧啶甲酸 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以76%的产率得到5-溴-2-吗啉嘧啶-4-羧酸
  参考文献：
  名称：

  2-氨基-5-卤代嘧啶-4-羧酸及其衍生物的一般和面部合成

  摘要：

  摘要 已经开发了一种从 5-卤素-2-甲基磺酰基嘧啶-4-羧酸通过用脂肪伯胺和仲脂肪胺亲核取代甲基磺酰基来合成 2-氨基-5-卤素-嘧啶-4-羧酸的简便方法。标题氨基酸经过脱羧，产生 2-氨基-5-卤代嘧啶。以2-氨基-5-氯嘧啶-4-甲酰氯为原料，得到2-[5-氯-2-(氨基)-4-嘧啶基]-2-氧代-1-(2-吡啶基)-乙基氰化物以优异的产量。

  DOI：

  10.1080/00397910701396930
• 作为产物：
  描述：

  5-溴-2-(甲巯基)-4-嘧啶甲酸 在 双氧水 、 溶剂黄146 作用下， 生成 2-甲砜基-5-溴-4-嘧啶甲酸
  参考文献：
  名称：

  2-氨基-5-卤代嘧啶-4-羧酸及其衍生物的一般和面部合成

  摘要：

  摘要 已经开发了一种从 5-卤素-2-甲基磺酰基嘧啶-4-羧酸通过用脂肪伯胺和仲脂肪胺亲核取代甲基磺酰基来合成 2-氨基-5-卤素-嘧啶-4-羧酸的简便方法。标题氨基酸经过脱羧，产生 2-氨基-5-卤代嘧啶。以2-氨基-5-氯嘧啶-4-甲酰氯为原料，得到2-[5-氯-2-(氨基)-4-嘧啶基]-2-氧代-1-(2-吡啶基)-乙基氰化物以优异的产量。

  DOI：

  10.1080/00397910701396930

文献信息

• MAJEED, AMERA J.;ANTONSEN, ZHIAMETRYVIND;BENNECHE, TORE;UNDNEIM, KJELL, TETRAHEDRON, 45,(1989) N, C. 993-1006
  作者：MAJEED, AMERA J.、ANTONSEN, ZHIAMETRYVIND、BENNECHE, TORE、UNDNEIM, KJELL

  DOI：——

  日期：——
• [EN] 2-SULFONYLPYRIMIDINES<br/>[FR] 2-SULFONYLPYRIMIDINES
  申请人：MEDICAL RES COUNCIL

  公开号：WO2017029498A1

  公开（公告）日：2017-02-23

  The invention relates to 2-sulfonylpyrimidine compounds and salts and solvates thereof for use in the treatment of a proliferative disease such as cancers. The 2- sulfonyl-primidine compounds may be administered, either simultaneously or sequentially, with one or more pharmacologically active compounds and salts and solvates thereof such as an inhibitor of glutamate cysteine ligase. The 2- sulfonylpyrimidine compound may be represented by formula (I): (I) wherein: R1 is selected from C1-6 alkyl, C6-12 aryl, C7-18 aralkyl, 6- to 15-membered heteroaralkyl and 6- to 12-membered heterocyclylalkyl wherein each of these groups are optionally substituted with from one to three optional substituents; R2 is selected from CF3, O-C(O)-R6, C(O)R7, C(O)NHR7 and NHC(O)R7; R3 is selected from H, F, CI, Br, I, OH, C1-6 alkyl, OC1-6 alkyl, CH2F, CHF2, CF3, CN, NO2, CO2R8, C(O)NHR10, NHC(O)R10, (CH2)z-NR8R9 and (CH2)z-NH-C(=NH)-NH2; R4 is selected from H, C1-6 alkyl and CH2R11; R5 is selected from C1-6 alkyl; R6 is selected from H and C1-6 alkyl; R7 is selected from 5 to 9-membered heteroaryl groups, and phenyl wherein these groups are optionally substituted with from one to three optional substituents; and wherein the heteroaryl group is attached to the rest of compound of formula (I) by a carbon ring atom; R8 and R9 are independently selected from H, C1-6 alkyl and benzyl; R10 is selected from 5- to 9-membered heteroaryl groups, 5- and 6-membered heterocyclyl, and phenyl wherein these groups are optionally substituted with from one to three optional substituents; R11 is phenyl optionally substituted; and z is selected from an integer selected from o to 6.
• General and Facial Synthesis of 2‐Amino‐5‐halogenpyrimidine‐4‐carboxylic Acids and Their Derivatives
  作者：Evgeniy V. Blyumin、Hans Neunhoeffer、Yulian V. Volovenko

  DOI：10.1080/00397910701396930

  日期：2007.7.1

  approach to 2‐amino‐5‐halogen‐pyrimidine‐4‐carboxylic acids from 5‐halogen‐2‐methylsulfonylpyrimidine‐4‐carboxylic acid by nucleophilic displacement of the methylsulfonyl group with primary and secondary aliphatic amines has been developed. The titled amino acids underwent decarboxylation, yielding 2‐amino‐5‐halogenpyrimidines. Starting from 2‐amino‐5‐chloropyrimidine‐4‐carboxylic acid chlorides, 2‐[5‐chl

  摘要 已经开发了一种从 5-卤素-2-甲基磺酰基嘧啶-4-羧酸通过用脂肪伯胺和仲脂肪胺亲核取代甲基磺酰基来合成 2-氨基-5-卤素-嘧啶-4-羧酸的简便方法。标题氨基酸经过脱羧，产生 2-氨基-5-卤代嘧啶。以2-氨基-5-氯嘧啶-4-甲酰氯为原料，得到2-[5-氯-2-(氨基)-4-嘧啶基]-2-氧代-1-(2-吡啶基)-乙基氰化物以优异的产量。